How Private Equity Is Buying Up Dental Lab Networks

Speaker A: You go to the dentist for a crown, they numb you up, drill down the tooth, take an impression and a couple weeks later you come back and they cement this thing in. But between that first visit and the second, someone actually has to make that crown, right?

Speaker B: A dental lab. I don't think most patients ever think about that step.

Speaker A: Exactly. And for a long time those labs were mostly small family owned shops. A technician with a bench, a furnace, some ceramic powder, maybe 10 employees. There are still about 7,000 of them

Speaker B: in the US but private equity has noticed big time.

Speaker A: And today I want to look at one specific network. National Dentex. It's the largest dental lab network in the country. Owned by the PE firm Lynden Capital Partners. They've been rolling up labs for years.

Speaker B: How big are we talking?

Speaker A: National Dentex now has about 40 labs across the U.S. doing north of $300 million in revenue. M and they're not alone. There's also Glidewell, which is privately held but huge, and a few other PE backed platforms.

Speaker B: So what's the pitch? Why is PE interested in dental labs?

Speaker A: It's a classic roll up story. The industry is fragmented. Most labs are small with maybe $2 to $5 million in revenue each. They serve local dentists. Relationships are sticky and there's a steady stream of work because people always need dental work. But the technology is shifting.

Speaker B: Digital dentistry, intraoral scanners, CAD, CAM milling, 3D printing.

Speaker A: Exactly. A small lab might not have the capital to buy a, ah, $100,000 milling machine or a fleet of 3D printers. But a P backed network can centralize that investment, bring down costs per unit and offer faster turnaround times.

Speaker B: That's the value creation thesis and the roll up economics. They can also negotiate better prices with material suppliers, streamline back office, maybe cross sell services.

Speaker A: Right. So Lyndon buys a lab, keeps the brand and local relationships, but plugs it into a shared digital workflow. The lab doesn't have to reinvent the wheel. They get access to a bigger ecosystem.

Speaker B: But there's a tension here. Dentists choose labs based on quality communication turnaround. If you centralize too much, do you lose that personal touch?

Speaker A: That's the big question. And it's not just a theoretical worry. Some dentists have complained that after their longtime lab gets acquired, they notice a drop in communication or a slower response when something goes wrong. The lab tech who used to answer the phone is gone.

Speaker B: So the consolidation might save money, but could also erode trust.

Speaker A: And that's the risk. But the PE firms are betting that scale wins in the Long run that digital workflows and lower costs will outweigh the relationship premium. And so far the numbers are supporting them. National Dentex has grown substantially.

Speaker B: Let's talk about Lynden Capital Partners. So specifically, they're a healthcare focused PE firm. What's their track record?

Speaker A: Lynden has been doing dental services and dental supply chain for years. They also own a company called Heartland Dental. That's a dso, a dental support organization that manages non clinical operations for dentists. So they understand the dentist's world.

Speaker B: So they see the lab as an adjacent piece of the puzzle.

Speaker A: Exactly. And they can potentially bundle services. If you're a dentist in their DSO network, why not use their lab too? That's the synergy play.

Speaker B: It's a smart vertical integration. But it also raises questions about competition. If one firm controls both the practice management and the lab, does that lock out independent labs?

Speaker A: Potentially. And that's the kind of thing regulators might start looking at. But for now, the PE roll up machine is still humming. And it's not just dental. We've seen the same pattern in veterinary diagnostics, in physical therapy, in funeral homes. The playbook is well established.

Speaker B: So what happens to the independent lab owner who gets a call from National Dentex or one of their competitors?

Speaker A: It's a tough decision. On one hand you get a liquidity event, a check that might be life changing. You also get access to resources you couldn't afford alone. On the other hand, you lose control. You become a branch manager, not an owner. And the culture can change fast.

Speaker B: And the employees, the master technicians who've been doing this for decades, they might not love working for a corporate parent.

Speaker A: That's the human side. And some labs have chosen to stay independent, betting that quality and relationships will keep them relevant. But the economics are getting harder, especially

Speaker B: as digital dentistry keeps advancing. Five years from now, a lot of crown work might be done chairside. The dentist mills it in the office while you wait. That could reduce the need for labs altogether.

Speaker A: That's the existential threat. Chairside milling and 3D printing are getting cheaper and more accurate. Some dentists already do same day crowns. If that becomes the norm, the lab industry shrinks dramatically.

Speaker B: So PE might be buying at the peak of the old model.

Speaker A: Or they're betting that they can be the ones to transition those labs into digital service centers. Hubs that do complex work the dentist can't do in office. That's the more optimistic view.

Speaker B: Interesting. So it's not just consolidation. It's a bet on the future shape of the industry, right?

Speaker A: And that's why this matters. Beyond just the lab owners, it affects the cost of dental care, the quality, the speed. And most patients have no idea any of this is happening.

Speaker B: That's a good point. And speaking of things people don't see, this show itself is listener supported. No ads, no sponsors, and a small group of listeners keeps it going by chipping in at buy me a coffee.com vexingo.

Speaker A: It's, um, a big help, and it lets us keep digging into these niche corners of finance without worrying about ad revenue. So thank you to those who do.

Speaker B: Yeah, it genuinely makes a difference. Now back to dental labs. One more angle I want to hit. What's the typical multiple a PE firm pays for a dental lab?

Speaker A: From what I've seen, it's usually in the range of six to eight times EBITDA. Uh, a lab doing $1 million in EBITDA might sell for $6 to $8 million. That's a solid exit for a founder. But the PE firm is going to try to double that EBITDA within five years through growth and cost synergies.

Speaker B: And if they succeed, they can sell the whole platform for a much higher multiple, maybe 10 or 11 times to a larger PE firm or a strategic buyer.

Speaker A: Exactly. That's the end game. And it's happening across healthcare services. Right now, dental labs are just one more tile in the mosaic.

Speaker B: I want to go back to the digital threat. Do you think the PE firms are underestimating how fast Chairside Dentistry might replace lab work?

Speaker A: It's possible, but I think most of them are aware and are positioning their labs as partners in the digital workflow. For, for example, some labs now offer design services. The dentist scans the tooth, sends the file to the lab, and the lab mills it. That's a hybrid model.

Speaker B: So the lab becomes more of a design and production hub rather than just a fabricator.

Speaker A: Right, and that requires skilled CAD CAM operators, which is a different skill set from traditional wax and cast techniques. That's another challenge, finding and retaining that talent.

Speaker B: So the consolidation might also accelerate the shift in the workforce.

Speaker A: No question. And it's not clear yet whether that's good or bad for patients, but it's worth watching.

Speaker B: All right, so to wrap up, dental labs are a quiet but important part of the dental supply chain. Private equity is consolidating them, betting on digital scale. The independent lab is under pressure, and the whole thing could be disrupted by Chairside technology.

Speaker A: That's the nutshell. And it's a reminder that PE roll ups aren't just about buying mom and Pops. They're about adapting an industry to new technology. Whether that adaptation benefits everyone is still an open question.

Speaker B: Good one to keep an eye on. That's it for today.